
Fate Therapeutics Inc Investor Relations Material
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Latest company events
More about Fate Therapeutics Inc
Ticker symbol
FATE
Country
United States of America